bpc 157 randomized controlled trial 2025 BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers Multifunctionality and Possible Medical Application

1998 Feb;83(2):362-9

It divides the scalp into four areas and calculates the percentage of hair loss 0% means full hair, 100% means complete baldness

Elsevier, 3770

If you notice any of the following, do not use the solution: Cloudiness that does not clear after gentle swirling Visible particles floating in the liquid Color changes from clear to yellow or any other tint Foam that does not dissipate after several minutes What Causes Problems Exposure to heat during shipping can damage peptides before you even begin to reconstitute Retatrutide

That is a very different evidence class than an FDA-approved drug carrying settled phase-three data, and the difference is clinically meaningful rather than a technicality